Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes

ClinicalTrials.gov ID: NCT01819129

Public ClinicalTrials.gov record NCT01819129. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 2:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT01819129
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
881 participants

Conditions and interventions

Interventions

  • Faster-acting insulin aspart Drug
  • Insulin aspart Drug
  • Insulin glargine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 8, 2013
Primary completion
Jan 21, 2015
Completion
Jan 21, 2015
Last update posted
Jan 29, 2019

2013 – 2015

United States locations

U.S. sites
77
U.S. states
27
U.S. cities
71
Facility City State ZIP Site status
Novo Nordisk Investigational Site Glendale Arizona 85306-4652
Novo Nordisk Investigational Site Glendale Arizona 85308
Novo Nordisk Investigational Site Mesa Arizona 85213
Novo Nordisk Investigational Site Phoenix Arizona 85020
Novo Nordisk Investigational Site Tempe Arizona 85283
Novo Nordisk Investigational Site Anaheim California 92801
Novo Nordisk Investigational Site Fresno California 93720
Novo Nordisk Investigational Site Greenbrae California 94904
Novo Nordisk Investigational Site Lomita California 90717
Novo Nordisk Investigational Site Northridge California 91325
Novo Nordisk Investigational Site San Diego California 92111
Novo Nordisk Investigational Site San Ramon California 94583
Novo Nordisk Investigational Site Walnut Creek California 94598
Novo Nordisk Investigational Site Aurora Colorado 80045
Novo Nordisk Investigational Site Colorado Springs Colorado 80910
Novo Nordisk Investigational Site Waterbury Connecticut 06708
Novo Nordisk Investigational Site Boynton Beach Florida 33472
Novo Nordisk Investigational Site Bradenton Florida 34201
Novo Nordisk Investigational Site Cooper City Florida 33024
Novo Nordisk Investigational Site Fort Lauderdale Florida 33316
Novo Nordisk Investigational Site Jacksonville Florida 32205
Novo Nordisk Investigational Site Jacksonville Florida 32216
Novo Nordisk Investigational Site Miami Florida 33144
Novo Nordisk Investigational Site Miami Florida 33173
Novo Nordisk Investigational Site Pembroke Pines Florida 33027
Novo Nordisk Investigational Site Plantation Florida 33324
Novo Nordisk Investigational Site Tampa Florida 33603
Novo Nordisk Investigational Site Atlanta Georgia 30308-2253
Novo Nordisk Investigational Site Atlanta Georgia 30328
Novo Nordisk Investigational Site Decatur Georgia 30033
Novo Nordisk Investigational Site Roswell Georgia 30076
Novo Nordisk Investigational Site Avon Illinois 46123
Novo Nordisk Investigational Site Peoria Illinois 61602
Novo Nordisk Investigational Site Indianapolis Indiana 46254
Novo Nordisk Investigational Site Muncie Indiana 47304
Novo Nordisk Investigational Site Topeka Kansas 66606
Novo Nordisk Investigational Site Louisville Kentucky 40206
Novo Nordisk Investigational Site Madisonville Kentucky 42431-1661
Novo Nordisk Investigational Site Paducah Kentucky 42003
Novo Nordisk Investigational Site Monroe Louisiana 71203
Novo Nordisk Investigational Site Buckley Michigan 49620
Novo Nordisk Investigational Site Detroit Michigan 48201
Novo Nordisk Investigational Site Troy Michigan 48085-5524
Novo Nordisk Investigational Site Chesterfield Missouri 63017
Novo Nordisk Investigational Site Jefferson City Missouri 65109
Novo Nordisk Investigational Site St Louis Missouri 63141
Novo Nordisk Investigational Site Butte Montana 59701
Novo Nordisk Investigational Site Elkhorn Nebraska 68022
Novo Nordisk Investigational Site Omaha Nebraska 68105
Novo Nordisk Investigational Site Omaha Nebraska 68198-3020
Novo Nordisk Investigational Site Toms River New Jersey 08755-8050
Novo Nordisk Investigational Site Mineola New York 11501
Novo Nordisk Investigational Site New Windsor New York 12553
Novo Nordisk Investigational Site North Massapequa New York 11758-1802
Novo Nordisk Investigational Site Northport New York 11768
Novo Nordisk Investigational Site Hickory North Carolina 28601
Novo Nordisk Investigational Site Wilmington North Carolina 28401
Novo Nordisk Investigational Site Carlisle Ohio 45005
Novo Nordisk Investigational Site Cleveland Ohio 44122
Novo Nordisk Investigational Site Dayton Ohio 45439
Novo Nordisk Investigational Site Franklin Ohio 45005
Novo Nordisk Investigational Site Mason Ohio 45040-6815
Novo Nordisk Investigational Site East Providence Rhode Island 02914
Novo Nordisk Investigational Site Gaffney South Carolina 29341
Novo Nordisk Investigational Site Chattanooga Tennessee 37404-1192
Novo Nordisk Investigational Site Kingsport Tennessee 37660
Novo Nordisk Investigational Site Spring Hill Tennessee 37174
Novo Nordisk Investigational Site Tullahoma Tennessee 37388
Novo Nordisk Investigational Site Dallas Texas 75230
Novo Nordisk Investigational Site Dallas Texas 75251
Novo Nordisk Investigational Site Hurst Texas 76054
Novo Nordisk Investigational Site Plano Texas 75075
Novo Nordisk Investigational Site Murray Utah 84123
Novo Nordisk Investigational Site Midlothian Virginia 23114
Novo Nordisk Investigational Site Port Orchard Washington 98366
Novo Nordisk Investigational Site Kenosha Wisconsin 53144
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 67 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01819129, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 29, 2019 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01819129 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →